Gca | search
Click here to view Gca news from 60+ newspapers.
Bookmark or Share- Giant cell arteritis: Current treatment and management - PMCCore tip: Giant cell arteritis (GCA) is the most common form of primary systemic vasculitis. Treatment with high doses of glucocorticoids should be initiated as early as possible to prevent ischaemic manifestations, such as blindness (occurring in up to 20%). However, glucocorticoid therapy leads to significant toxicity in over 80% of the patients.
- Treatment of giant cell arteritis - UpToDateGiant cell arteritis (GCA, also known as Horton disease, cranial arteritis, and temporal arteritis) is the most common systemic vasculitis in North America and Europe [ 1,2 ]. GCA affects only older adults, with a peak incidence between ages 70 and 79 [ 3 ].
- Giant Cell Arteritis : Johns Hopkins Vasculitis CenterGiant cell arteritis (GCA) is the most common form of vasculitis that occurs in adults. Almost all patients who develop giant cell arteritis are over the age of 50. GCA commonly causes headaches, joint pain, facial pain, fever, and difficulties with vision, and sometimes permanent visual loss in one or both eyes.
- What Is Giant Cell Arteritis? - American Academy of OphthalmologyGiant cell arteritis (GCA) is an inflammation (swelling) of the arteries (the blood vessels that carry blood away from the heart). When arteries swell, it reduces blood flow through these vessels. GCA affects the arteries in the neck, upper body and arms. It is also called cranial or temporal arteritis because it affects the head (cranium).
- Giant Cell Arteritis - Vasculitis FoundationGiant cell arteritis (GCA) is a form of vasculitis—a family of rare disorders characterized by inflammation of the blood vessels, which can restrict blood flow and damage vital organs and tissues. Also called temporal arteritis, GCA typically affects the arteries in the neck and scalp, especially the temples.
More
